Shareholders Equity: The sum of preferred and common equity items.
Pacira BioSciences, Inc. (PCRX) had Shareholders Equity of $757.77M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$181.10M |
|
$-4.85M |
|
$40.87M |
|
$140.23M |
|
$172.60M |
|
$8.50M |
|
$-10.43M |
|
$-1.93M |
|
$-1.93M |
|
$-4.85M |
|
$-4.85M |
|
$-4.85M |
|
$-4.85M |
|
$8.50M |
|
$36.69M |
|
45.46M |
|
45.46M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$745.61M |
|
$155.18M |
|
$791.65M |
|
$1.54B |
|
$313.16M |
|
$378.10M |
|
$466.33M |
|
$779.50M |
|
$757.77M |
|
$314.90M |
|
|
Shareholders Equity |
$757.77M |
44.90M |
|
| Cash Flow Statement Financials | |
$47.47M |
|
$36.53M |
|
$-60.50M |
|
$276.77M |
|
$300.48M |
|
$23.71M |
|
$30.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
0.33 |
|
0.77 |
|
77.43% |
|
4.69% |
|
4.69% |
|
-- |
|
-1.06% |
|
-2.68% |
|
$36.23M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.28 |
|
1.58 |
|
56.84 |
|
-0.64% |
|
-1.54% |
|
-0.32% |
|
-0.43% |
|
$16.88 |
|
$0.80 |
|
$1.04 |
|